[go: up one dir, main page]

Aguzzi et al., 2003 - Google Patents

Immune system and peripheral nerves in propagation of prions to CNS

Aguzzi et al., 2003

View HTML
Document ID
11638788889754179918
Author
Aguzzi A
Heppner F
Heikenwalder M
Prinz M
Mertz K
Seeger H
Glatzel M
Publication year
Publication venue
British medical bulletin

External Links

Snippet

Prions are not only unique in the way they replicate. Also the sequence of events triggered by peripheral prion infection, generically termed 'peripheral pathogenesis', sets prions aside from all other known pathogens. Whereas most bacteria, parasites, and viruses trigger …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Similar Documents

Publication Publication Date Title
Aguzzi et al. Immune system and peripheral nerves in propagation of prions to CNS
AGUZZI¹ Spleen, and Nerves
Aguzzi et al. Molecular mechanisms of prion pathogenesis
Brouillette et al. Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1–42 oligomers are revealed in vivo by using a novel animal model
Aguzzi et al. Antiprion immunotherapy: to suppress or to stimulate?
Klein et al. A crucial role for B cells in neuroinvasive scrapie
Kahn et al. Prevention of murine antiphospholipid syndrome by BAFF blockade
Aguzzi et al. Toward therapy of human prion diseases
Mabbott et al. Prions and their lethal journey to the brain
Ballerini et al. Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells
Kong et al. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models
Montrasio et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells
Safar et al. Transmission and detection of prions in feces
Polymenidou et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection
Hinson et al. Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor
Mallucci et al. Rational targeting for prion therapeutics
Mathiason et al. B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease
Aguzzi Prion diseases, blood and the immune system: concerns and reality
Nogai et al. Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells
Kaeser et al. Efficient lymphoreticular prion propagation requires PrPc in stromal and hematopoietic cells
Sibilla et al. Prion properties of SOD1 in amyotrophic lateral sclerosis and potential therapy
Le et al. Prion neurotoxicity
Li et al. N-terminally deleted forms of the prion protein activate both Bax-dependent and Bax-independent neurotoxic pathways
Jambeau et al. Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9orf72 disease
Miyake et al. IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model